ERBB2 and cancer: Of the molecular-polytypic cancers, one case was a clinical IHC-classified HER2 3+ (HR-negative) and two were clinical IHC-classified triple-negative breast cancers (TNBC) (See Table S.II for a detailed description of the IHC-classification and molecular-subtypes classification of the cores and cases).